• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDELA LLC PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN); PUMP, BREAST, POWERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDELA LLC PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN); PUMP, BREAST, POWERED Back to Search Results
Model Number 101041360
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 02/09/2023
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2023, the customer alleged to medela llc that she was experiencing low suction with her pump in style max flow breast pump.She additionally alleged she had mastitis and was prescribed antibiotics.
 
Additional Manufacturer Narrative
Customer service conducted troubleshooting including verifying the user was using correct kit components; verifying the user was washing parts according to instructions for use; verifying user was using dry parts when pumping; verifying the user was not washing or drying tubing on the pump; verifying there was no milk backup; and disassembling, inspecting, cleaning and/or reassembling kit and tubing set.The customer was contacted by a complaint handler on multiple occasions, including in writing, to get additional information, with no response as of the date of this report.Based on the results of our internal investigation (reference number ca11-001), it cannot be definitively concluded that the pump caused or contributed to the customer¿s mastitis.The estimated incidence of mastitis in lactating women, whether using a breast pump or not, according to published clinical literature can be as high as 33%.In fact, clinical guidelines suggest the use of a breast pump to facilitate withdrawal of breast milk during bouts of mastitis.The complaint rate of mastitis across all reported failures, across all medela breast pumps, is 0.008% for the period of january 2013 to august 2017.Mastitis is usually a benign, self-limiting infection with few consequences for the suckling infant.The risk of mastitis is higher among women who have breastfed previously, especially those with a history of mastitis.Riordan & wambach, 4th ed.P.294: breastfeeding and human lactation.However, in this case, the mother¿s mastitis required prompt medical attention for pain relief and prescription antibiotics to avoid progression to overwhelming sepsis.
 
Additional Manufacturer Narrative
The device was returned without the customer's parts and accessories; therefore, it was evaluated with a medela lab kit on 03/09/2023 and it passed suction and cycle specifications.The customer's report of low suction could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN)
Common Device Name
PUMP, BREAST, POWERED
Manufacturer (Section D)
MEDELA LLC
1101 corporate dr
mchenry IL 60050
Manufacturer (Section G)
MEDELA LLC
1101 corporate dr
mchenry IL 60050
Manufacturer Contact
tom cuzman
1101 corporate drive
mchenry, IL 60050
8004358316
MDR Report Key16428175
Report Number1419937-2023-00009
Device Sequence Number2662127
Product Code HGX
UDI-Device Identifier00020451401447
UDI-Public020451401447
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K200508
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number101041360
Device Catalogue Number101041360
Device Lot Number0000262064
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Distributor Facility Aware Date02/09/2023
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/09/2023
Supplement Date Received by Manufacturer03/09/2023
Initial Report FDA Received Date02/23/2023
Supplement Report FDA Received Date03/10/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/03/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-